Oral Thin Films Market Report and Forecast 2023-2031

The global oral thin films market attained a value of USD 3.3 billion in 2022, driven by the rising demand for patient-friendly and convenient drug delivery systems. The market is expected to grow at a CAGR of 8.98% during the forecast period of 2023-2031 to attain a value of USD 7.1 billion by 2031.

Oral Thin Films: Introduction

Oral thin films (OTFs) are a type of drug delivery system that consists of thin, flexible strips that are placed on or under the tongue, where they rapidly dissolve and release medication. These films offer several uses and benefits in the field of pharmaceuticals.

The benefits of oral thin films include:

• Improved Patient Compliance: The ease of administration and convenience of oral thin films can improve patient compliance with medication regimens. Patients who have difficulty swallowing tablets or capsules may find oral thin films more manageable, leading to better adherence to prescribed therapies
• Enhanced Bioavailability: Oral thin films allow for direct absorption of drugs through the mucosal tissues in the oral cavity, bypassing the gastrointestinal tract and potential degradation in the digestive system. This can result in improved drug bioavailability and therapeutic efficacy
• Reduced First-Pass Metabolism: By avoiding the first-pass metabolism in the liver, oral thin films can help enhance drug bioavailability. This is particularly advantageous for drugs with high hepatic metabolism or drugs that undergo significant degradation during gastrointestinal transit
• Precise Dosage Control: Oral thin films enable precise dosing, allowing for accurate delivery of medications. This can be beneficial for drugs with narrow therapeutic ranges or those requiring specific titration or individualized dosing
• Versatility and Formulation Flexibility: Oral thin films offer versatility in formulation, allowing for the incorporation of a wide range of active pharmaceutical ingredients (APIs) and excipients. This flexibility enables the development of different drug delivery strategies, including controlled release formulations, combination therapies, and targeted drug delivery

Overall, oral thin films provide a patient-friendly and efficient drug delivery system that offers convenience, rapid drug absorption, taste masking, and dose flexibility. Their potential applications span various therapeutic areas, making them a promising alternative to traditional oral dosage forms in the pharmaceutical industry.

Oral Thin Films Market Segmentations

The market can be categorised into products, disease indication, end user, and region.

Market Breakup by Products

• Sublingual Film
• Other Products

Market Breakup by Disease Indication

• Opioid Dependence
• Nausea and Vomiting
• Other Disease Indications

Market Breakup by End User

• Hospital Pharmacies
• Retail Pharmacies
• Other Distribution Channels

Oral Thin Films Market Breakup by Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East and Africa

Oral Thin Films Market Scenario

The market has witnessed significant growth in recent years and is projected to continue expanding. Several factors contribute to the positive market scenario.

One of the key drivers of market growth is the increasing demand for patient-friendly and convenient drug delivery systems. Oral thin films offer a user-friendly alternative to traditional oral dosage forms, such as tablets or capsules, particularly for patients who have difficulty swallowing or those who prefer a more discreet and portable medication option. The ease of administration and portability of OTFs contribute to improved patient compliance and medication adherence, driving the market growth.

Moreover, advancements in formulation technologies and manufacturing processes have enhanced the development and commercialization of oral thin films. Formulation techniques, such as taste-masking technologies, have improved the palatability of medications, making them more acceptable to patients. Additionally, the ability to incorporate precise dosages and control drug release in oral thin films has opened avenues for personalized medicine and customized drug delivery.

Key players in the global oral thin films market

The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the oral thin films market are as follows:

• Aquestive Therapeutics Inc
• LTS Lohmann Therapie-Systeme AG
• IntelGenx Corp
• C.L.Pharm
• CURE Pharmaceutical
• ZIM Laboratories Limited
• Viatris
• Sunovion Pharmaceuticals Inc

*The publisher always strives to provide you with the latest information. The numbers in the article are only indicative and may be different from the actual report.